Clinical Trials Directory

Trials / Unknown

UnknownNCT03082378

Central Obesity and Hepatocellular Carcinoma

Central Obesity and the Prognosis of Hepatocellular Carcinoma After Microwave Ablation

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Recurrence and metastases after microwave ablation(MWA) of hepatocellular carcinoma(HCC) are the major factors that influence the survival. Obesity has been reported was significantly correlated with increased risk of developing HCC. In this study, we will analysis the association of multiple obesity index(waist circumference,waist-hip ratio and body mass index) with the prognosis of HCC treated by MWA.

Conditions

Timeline

Start date
2017-03-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-03-17
Last updated
2017-03-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03082378. Inclusion in this directory is not an endorsement.